Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Joint Bone Spine|May 29, 2025
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE CohortPascal Claudepierre, Cecile Gaujoux-Viala, Arnaud Constantin, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|February 19, 2013
Intra-articular hylastan versus steroid for knee osteoarthritisLawrence Housman, Nigel Arden, Thomas J Schnitzer, et al.
Rheumatology and Therapy|December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 TrialsGerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Joint Bone Spine|June 26, 2007
Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionEmmanuelle Dernis, Frédéric Lavie, Stéphan Pavy, et al.
Joint Bone Spine|June 26, 2007
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionFrédéric Lavie, Stephan Pavy, Emmanuelle Dernis, et al.
Joint Bone Spine|June 27, 2007
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionStephan Pavy, Emmanuelle Dernis, Frédéric Lavie, et al.
Arthritis Research & Therapy|March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational studyFernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
Lancet (London, England)|May 11, 2020
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trialIain B McInnes, Frank Behrens, Philip J Mease, et al.
Rheumatology (Oxford, England)|May 7, 2021
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohortBernard Combe, Nathalie Rincheval, Francis Berenbaum, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohortDewi Guellec, Guillermo Carvajal-Alegria, Claire Daïen, et al.
Pageof 13